Form 8-K LEXICON PHARMACEUTICALS, For: Oct 16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. CVS
9. UNH
10. SPY

Go back to Form 8-K LEXICON PHARMACEUTICALS, For: Oct 16

Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at Leerink Partners

October 18, 2024 5:48 AM EDT

Leerink Partners analyst Roanna Ruiz raised the price target on Lexicon Pharmaceuticals (NASDAQ: LXRX) to $6.00 (from $5.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: We see Lexicons (LXRX) exclusive licensing agreement with Viatris [VTRS, Not Rated, LINK] for sotagliflozin (sota) in all rest-of world (RoW) markets outside of US/Europe as... More